Mirum Pharmaceuticals, Inc. revenue breakdown overview

Mirum Pharmaceuticals, Inc. revenue for the last year amounted to 186.37 M USD, the most of which — 186.37 M USD — came from its highest performing source at the moment, Novel Therapies, the year earlier bringing 77.06 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Mirum Pharmaceuticals, Inc. 146.70 M USD, and the year before that — 77.06 M USD.